As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Our systems will continue to remind authors, reviewers and editors of the original timelines but we intend to be highly flexible at this time.
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus
In current management of type 2 diabetes (T2DM), cardiovascular and renal prevention have become important targets to be achieved. In this context, a joint panel of four endocrinology societies from Brazil and Portugal was established to develop an evidence-based guideline for treatment of hyperglycemia in T2DM.
Articles
-
-
Gender discrepancy of incidence and risk factors of metabolic syndrome among rural Chinese from 2012–2013 to 2015–2017
-
Phenotyping individuals with newly-diagnosed type 2 diabetes at risk for all-cause mortality: a single centre observational, prospective study
-
Metabolic syndrome is associated with better quality of sleep in the oldest old: results from the “Mugello Study”
-
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus
-
Metformin: an old but still the best treatment for type 2 diabetes
-
The effect of vitamin D on insulin resistance in patients with type 2 diabetes
-
Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study
-
Combination therapy in hypertension: An update
-
Effects of zinc supplementation on diabetes mellitus: a systematic review and meta-analysis
Announcement: Covid-19
Aims and scope
Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome.
By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.
The journal aims to help health care providers improve the management of people afflicted by these syndromes by increasing knowledge and stimulating research in the field.
About the editor
Editor-in-Chief Dr. Sérgio Vencio is active in the field of Endocrinology. He is a professor in the Post Graduate Program at the Federal University of Goiás, a Principal Investigator at the Pharmaceutical Institute of Science and has participated as a PI in more than 70 clinical studies. Since 2008, he has been the Editor of the Brazilian Diabetes Society Guidelines. He is the Coordinator of Neuroendocrinology at the Hospital Araujo Jorge, the Medical Director at Diagnostics of America - Atalaia, and a member of the Diabetes Board for the Brazilian Society of Endocrinology.
Advertisement
The official journal of the Brazilian Diabetes Society.
Annual Journal Metrics
-
Speed
43 days to first decision for reviewed manuscripts only
27 days to first decision for all manuscripts
97 days from submission to acceptance
11 days from acceptance to publication
Citation Impact
2.361 - 2-year Impact Factor
2.466 - 5-year Impact Factor
0.835 - SNIP (Source-Normalized Impact per Paper)
0.925 - SJR (SCImago Journal Rank)
Usage
525,338 Downloads
157 Altmetric Mentions
Advertisement
